Dashboard
Manage Tickers

PFEPFIZER INC

NYSE pfizer.com


$ 28.82 $ 0.10 (0.35 %)    

Friday, 30-Aug-2024 13:00:17 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.73 $ -2.64 (-0.56 %)
DIA $ 413.31 $ -1.54 (-0.37 %)
SPY $ 559.10 $ 0.75 (0.13 %)
TLT $ 96.83 $ -0.70 (-0.72 %)
GLD $ 230.85 $ -2.10 (-0.9 %)
$ 28.72
$ 28.77
$ 28.81 x 2,100
$ 28.82 x 1,900
$ 28.67 - $ 28.90
$ 24.48 - $ 34.27
19,229,826
na
162.75B
$ 0.55
nm
TBD
na
na ($ 0.06)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 02-22-2024 12-31-2023 10-K
4 11-08-2023 10-01-2023 10-Q
5 08-09-2023 07-02-2023 10-Q
6 05-10-2023 04-02-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-09-2022 10-02-2022 10-Q
9 08-10-2022 07-03-2022 10-Q
10 05-11-2022 04-03-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-12-2021 10-03-2021 10-Q
13 08-12-2021 07-04-2021 10-Q
14 05-13-2021 04-04-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 11-05-2020 09-27-2020 10-Q
17 08-06-2020 06-28-2020 10-Q
18 05-07-2020 03-29-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 11-07-2019 09-29-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-09-2018 07-01-2018 10-Q
26 05-10-2018 04-01-2018 10-Q
27 02-22-2018 12-31-2017 10-K
28 11-09-2017 10-01-2017 10-Q
29 08-10-2017 07-02-2017 10-Q
30 05-11-2017 04-02-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 11-10-2016 10-02-2016 10-Q
33 08-11-2016 07-03-2016 10-Q
34 05-12-2016 04-03-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 11-05-2015 09-27-2015 10-Q
37 08-06-2015 06-28-2015 10-Q
38 05-07-2015 03-29-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-06-2014 09-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

alnylam-pharmaceuticals-stock-falls-after-detailed-vutrisiran-data-for-a-condition-with-stiff-heart-muscles
Alnylam Pharmaceuticals Stock Falls After ...
08/30/2024 13:51:46

Alnylam Pharmaceuticals shares drop as detailed results from the HELIOS-B Phase 3 study of vutrisiran for ATTR-CM reveal mixed ...

a-closer-look-at-pfizers-options-market-dynamics
A Closer Look at Pfizer's Options Market D...
08/29/2024 14:46:41

reported-earlier-flagship-pioneering-expands-strategic-partnership-with-pfizer-through-two-new-research-programs-with-quotient-therapeutics-focusing-on-somatic-mutations-for-cardiovascular-and-renal-disease-therapies-latest-initiative-under-july-2023-collaboration
Reported Earlier: Flagship Pioneering Expa...
08/28/2024 14:45:32

pfizer-launches-pfizerforall-streamlining-healthcare-access-with-a-comprehensive-digital-platform
Pfizer Launches PfizerForAll, Streamlining...
08/27/2024 10:48:17

PfizerForAll makes managing everyday health quicker and more convenient for millions of Americans Platform is designed for p...

americans-to-access-covid-19-test-kits-for-free-as-us-government-restarts-free-at-home-program
Americans To Access COVID-19 Test Kits For...
08/26/2024 15:24:26

US households can order free COVID-19 tests starting in late September as the government reopens the program ahead of the fall ...

novo-nordisks-ozempic-might-be-among-2027-medicare-price-negotiation-targets
Novo Nordisk's Ozempic Might Be Among 2027...
08/23/2024 18:21:18

Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite co...

Core News & Articles
U.S. CDC Says For This Season Peak Hospita...
08/23/2024 15:51:38

- Press Conference

fda-approves-updated-covid-vaccines-from-pfizer-and-moderna-but-leaves-out-novavaxs-shot
FDA Approves Updated COVID Vaccines From P...
08/22/2024 18:33:49

The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new...

Core News & Articles
FDA Authorizes Updated Covid-19 Vaccines B...
08/22/2024 17:30:58

- Bloomberg

fda-warns-of-aluminum-toxicity-risk-in-infants-from-unapproved-potassium-phosphates-drug-notes-some-hospitals-still-using-hospiras-product-hospira-agrees-to-stop-distribution-within-90-days
FDA Warns Of Aluminum Toxicity Risk In Inf...
08/21/2024 16:57:50

- Reuters 

pfizers-options-frenzy-what-you-need-to-know
Pfizer's Options Frenzy: What You Need to ...
08/21/2024 15:45:36

Core News & Articles
WHO Official Hans Kluge Asserts Mpox Is No...
08/20/2024 17:25:45

- Reuters 

cantor-fitzgerald-reiterates-overweight-on-pfizer-maintains-45-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/19/2024 16:28:43

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

fda-set-to-approve-covid-19-vaccines-as-soon-as-this-week-stocks-etfs-to-watch
FDA Set To Approve COVID-19 Vaccines As So...
08/19/2024 16:08:30

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer ou...

pfizer-biontechs-covid-19flu-combo-vaccine-fails-to-meet-key-goal-in-late-stage-study
Pfizer, BioNTech's COVID-19/Flu Combo Vacc...
08/16/2024 13:19:30

Pfizer and BioNTech report Phase 3 results for their combined mRNA vaccine against influenza and COVID-19. The trial met one of...

florida-ruling-upholds-gsks-stance-on-once-popular-heart-burn-drug-zantac-not-being-associated-with-cancer-risk
Florida Ruling Upholds GSK's Stance On Onc...
08/16/2024 13:00:55

A Florida State Court sided with GSK, dismissing expert testimonies that linked ranitidine to prostate cancer, reflecting a bro...

Core News & Articles
Pfizer And BioNTech Provide Update On mRNA...
08/16/2024 10:50:13

The trial did not meet one of its primary immunogenicity objectives of non-inferiority against the influenza B strain despite o...

pfizer-conagra-brands-and-2-other-stocks-insiders-are-selling
Pfizer, Conagra Brands And 2 Other Stocks ...
08/15/2024 12:24:03

eli-lilly-smashed-estimates-thanks-to-unbelievable-demand-for-its-diabetes-and-weight-loss-blockbusters
Eli Lilly Smashed Estimates Thanks To Unbe...
08/14/2024 14:26:17

On Thursday, Eli Lilly and Company (NYSE: LLY) reported its second quarter results, smashing estimates fueled by the popularity...

struggling-covid-19-vaccines-from-astrazeneca-biontechpfizer-moderna-cut-incidence-of-arterial-thromboses-that-cause-heart-attacks-strokes-british-study-shows
Struggling COVID-19 Vaccines From AstraZen...
08/13/2024 18:43:35

COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION